• FirefoxInstall the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.35%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    12.82 Up 0.04(0.31%) 9:39AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 569   256   -   10,000  
    Cost of Revenue341  154   -   -  
    Gross Profit 228   102   -   10,000  
    Operating Expenses
    Research Development5,815  19,053  11,079  15,555  
    Selling General and Administrative34,050  16,447  11,464  8,096  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (39,637) (35,398) (22,543) (13,651)
    Income from Continuing Operations
    Total Other Income/Expenses Net52  109  129  121  
    Earnings Before Interest And Taxes(39,585)(35,289)(22,414)(13,530)
    Interest Expense -   -   -   -  
    Income Before Tax(39,585)(35,289)(22,414)(13,530)
    Income Tax Expense700   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(40,285)(35,289)(22,414)(13,530)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (40,285) (35,289) (22,414) (13,530)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (40,285) (35,289) (22,414) (13,530)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.